ArticleThe Journal of clinical investigation2026

PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer.

Jie Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.